Fischer Medical Ventures Intrinsic Value
FISCHER Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹103.20 | ₹82.56 - ₹123.84 | +150.4% | EPS: ₹8.60, Sector P/E: 12x |
| Book Value Method | asset | ₹52.81 | ₹47.53 - ₹58.09 | +28.1% | Book Value/Share: ₹52.81, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹44.50 | ₹40.05 - ₹48.95 | +8.0% | Revenue/Share: ₹55.62, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹71.25 | ₹64.12 - ₹78.38 | +72.9% | EBITDA: ₹76.00Cr, EV/EBITDA: 6x |
| PEG Ratio Method | growth | ₹55.04 | ₹49.54 - ₹60.54 | +33.6% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹70.86 | ₹63.77 - ₹77.95 | +71.9% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹82.42 | ₹74.18 - ₹90.66 | +100.0% | ROE: 16.6%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹101.09 | ₹90.98 - ₹111.20 | +145.3% | EPS: ₹8.60, BVPS: ₹52.81 |
Want to compare with current market value? Check FISCHER share price latest .
Valuation Comparison Chart
FISCHER Intrinsic Value Analysis
What is the intrinsic value of FISCHER?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Fischer Medical Ventures (FISCHER) is ₹71.25 (median value). With the current market price of ₹41.21, this represents a +72.9% variance from our estimated fair value.
The valuation range spans from ₹44.50 to ₹103.20, indicating ₹44.50 - ₹103.20.
Is FISCHER undervalued or overvalued?
Based on our multi-method analysis, Fischer Medical Ventures (FISCHER) appears to be trading below calculated value by approximately 72.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 20.28 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.35 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 16.6% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 19.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Fischer Medical Ventures
Additional stock information and data for FISCHER
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-87 Cr | ₹-150 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-7 Cr | ₹-22 Cr | Negative Cash Flow | 3/10 |